Evidence map›Paper›PMID 39474991›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Pristine MXene: In Situ XRD Study of MAX Phase Etching with HCl+LiF Solution.

Bartosz Gurzęda, Nicolas Boulanger, Andreas Nordenström, Catherine Dejoie, Alexandr V Talyzin

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Advanced Characterization of 2D Materials Using SLEEM/ToF.Nanomaterials (Basel, Switzerland) · 2026
    Article
  9. Article
  10. Recent advances in TiNanoscale advances · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Pristine MXene: In Situ XRD Study of MAX Phase Etching with HCl+LiF Solution.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bartosz GurzędaDepartment of Physics, Umeå University, Umeå, S-90187, Sweden.
Nicolas BoulangerDepartment of Physics, Umeå University, Umeå, S-90187, Sweden.
Andreas NordenströmDepartment of Physics, Umeå University, Umeå, S-90187, Sweden.
Catherine DejoieEuropean Synchrotron Radiation Facility (ESRF), ID22 Beamline, 71 Avenue des Martyrs, Grenoble, 38000, France.
Alexandr V TalyzinDepartment of Physics, Umeå University, Umeå, S-90187, Sweden.ORCID https://orcid.org/0000-0002-3320-8487

Funding

Energimyndigheten 50620-1ESRF MA/5897Kempestiftelserna
6 · The paper itself

Abstract

Many applications are suggested for Ti-MXene motivating strong interest in studies of Ti

Indexed as

2D materialsin situ synthesisMXenesynchrotron radiationTi3C2TxX‐ray diffraction

Identifiers

PMID39474991
PMCPMC11672266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.